UNC Lineberger News

Endeavors - Chasing Pac-Man

Endeavors - Chasing Pac-Man

Two UNC researchers design a biological test to individualize chemotherapy.

Endeavors - Chasing Pac-Man - Read More…

Weiss teams up with GRACE to offer free webinar for late stage oropharynx cancer patients

UNC Lineberger Comprehensive Cancer Center member Jared Weiss, MD is teaming up with the cancer advocacy organization Global Resource for Advancing Cancer Education (GRACE) to offer a free webinar

Weiss teams up with GRACE to offer free webinar for late stage oropharynx cancer patients - Read More…

UNC Lineberger members make major contribution to President’s Cancer Panel report on HPV vaccination

Members of the University of North Carolina Lineberger Comprehensive Cancer Center played a major role in developing the recommendations in a President’s Cancer Panel (PCP) report urging a widespread public campaign to increase the rate of human papillomavirus (HPV) vaccination.

UNC Lineberger members make major contribution to President’s Cancer Panel report on HPV vaccination - Read More…

Baron aspirin research profiled in the Boston Globe

Baron aspirin research profiled in the Boston Globe

The work of UNC School of Medicine Professor and Lineberger member John Baron, MD, is featured in an article titled "Can aspiring fight cancer?" The article provides an overview of recent studies that suggest regular doses of aspirin can help prevent some types of cancer.

Baron aspirin research profiled in the Boston Globe - Read More…

UNC Lineberger faculty headline AACR RAS conference

UNC Lineberger faculty headline AACR RAS conference

The oncogene RAS is linked to 30 percent of human cancers, but the search for a targeted therapy for RAS has remained elusive. Three leading RAS researchers from the University of North Carolina Lineberger Comprehensive Cancer Center are playing leading roles at a conference aimed at discussing recent advances that may lead to new advances in targeting the oncogene.

UNC Lineberger faculty headline AACR RAS conference - Read More…

Clinical advances should not yet discourage the use of local therapies

Clinical advances should not yet discourage the use of local therapies

Clinical trials that show positive patient response to systemic therapies for cancer should not necessarily lead to reduction in the use of local therapies such as radiation and surgery.

Clinical advances should not yet discourage the use of local therapies - Read More…

UNC’s Dr. Jared Weiss joins Lung Cancer Initiative of North Carolina’s Board

UNC’s Dr. Jared Weiss joins Lung Cancer Initiative of North Carolina’s Board

The Lung Cancer Initiative of North Carolina (LCINC), the state’s leading non-profit organization supporting lung cancer research and education, is proud to welcome Dr. Jared Weiss, medical oncologist with UNC Lineberger Comprehensive Cancer Center’s Thoracic Oncology Program, to serve on the board of directors.

UNC’s Dr. Jared Weiss joins Lung Cancer Initiative of North Carolina’s Board - Read More…

Harris comments on major mammography study in The New York Times

Harris comments on major mammography study in The New York Times

UNC Lineberger member Russell Harris, MD, MPH, Professor of Medicine in the UNC School of Medicine and Adjunct Professor of Epidemiology in the UNC Gillings Global School of Public Health, was quoted in two articles in the New York Times about a major study of the efficacy of breast cancer screening published by BMJ (formerly British Medical Journal).

Harris comments on major mammography study in The New York Times - Read More…

Genetic subtypes of bladder cancer reflect breast cancer biology

Genetic subtypes of bladder cancer reflect breast cancer biology

A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.

Genetic subtypes of bladder cancer reflect breast cancer biology - Read More…

Makowski study explores impact of glucose uptake on inflammatory processes

Makowski study explores impact of glucose uptake on inflammatory processes

“This is an important finding because of the field’s increased interest in ‘metabolic reprogramming’ of immune cells. Understanding how macrophage substrate metabolism impacts inflammation is crucial to our being able to develop novel therapies for obesity and diabetes, and even cancer," said study author Liza Makowski, PhD, assistant professor of nutrition at the Gillings School and member of the UNC Lineberger Comprehensive Cancer Center.

Makowski study explores impact of glucose uptake on inflammatory processes - Read More…